Chinese baby food maker Synutra has swung into the red during its fiscal fourth quarter due to the fall-out of last year’s melamine contamination scandal.


Synutra booked a net loss of US$17.2m for the three months to 31 March compared to net income of $19.3m.


Sales slumped by 32.8% to $72.7m due to the link between Synutra and last autumn’s melamine scandal that caused thousands of infants to fall sick and the deaths of at least six babies.


Amid the scandal, batches of Synutra’s U-Smart products were discovered to be contaminated with melamine, which caused sales to tumble.


Across the full fiscal year, Synutra incurred a net loss of US$100.6m, with sales down 13.7% to US$312.5m.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Chairman and CEO Liang Zhang admitted the last 12 months had been the “most painful and difficult “ in the company’s history.


However, the Synutra boss insisted its fourth-quarter results showed the company was making “good progress”.


“The rising sales and narrowing losses demonstrated in our sequential results make us increasingly confident that we can return to profitability and financial stability by the end of the current fiscal year, which ends on 31 March, 2010.”


Compared to Synutra’s fiscal third quarter, sales soared by 311% during its fourth quarter, while its losses narrowed.